|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7500 GBX | -.--% |
|
+3.45% | -91.89% |
| 10-01 | EARNINGS: Next 15 profit falls; 4basebio and Mollyroe losses widen | AN |
| 09-22 | Belluscura plc Announces Termination of Robert Rauker as Director, Effective September 22, 2025 | CI |
| Capitalization | 19.5M 16.76M 15.72M 14.65M 26.98M 1.75B 29.32M 182M 70.85M 831M 73.18M 71.63M 3.06B | P/E ratio 2022 |
-11.6x | P/E ratio 2023 | -2.06x |
|---|---|---|---|---|---|
| Enterprise value | 17.57M 15.09M 14.16M 13.19M 24.3M 1.58B 26.41M 164M 63.82M 748M 65.92M 64.53M 2.76B | EV / Sales 2022 |
68.2x | EV / Sales 2023 | 46.5x |
| Free-Float |
36.51% | Yield 2022 * |
-
| Yield 2023 | - |
More valuation ratios
* Estimated data
More news
| 6 months | -14.29% | ||
| Current year | -91.89% |
| Current year | 0.49 |  | 10 |
| 1 year | 0.49 | | 10.4 |
| 3 years | 0.49 | | 79.7 |
| 5 years | 0.49 | | 152 |
| 10 years | 0.49 | | 152 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Rauker
CEO | Chief Executive Officer | - | 17/08/2016 |
Brian Brown
COO | Chief Operating Officer | - | - |
Jim Clement
PRN | Corporate Officer/Principal | - | 04/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Tuson
CHM | Chairman | 58 | - |
Guy Peters
BRD | Director/Board Member | 64 | 11/09/2025 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.45% | -92.68% | -98.97% | 4.01M | |
| -0.44% | -3.72% | +5.85% | +13.12% | 212B | |
| -0.75% | -1.51% | +19.69% | +27.87% | 130B | |
| +0.83% | -2.81% | +41.70% | +106.14% | 65.53B | |
| -0.03% | -0.49% | -15.01% | -23.45% | 54.09B | |
| -1.36% | +2.30% | +16.34% | +76.12% | 51.91B | |
| -0.39% | +0.41% | +20.74% | +35.63% | 25.66B | |
| -0.52% | +1.21% | -16.81% | -43.99% | 25.59B | |
| -1.61% | +0.34% | +12.88% | -33.66% | 23.91B | |
| -0.84% | -1.72% | -23.72% | +20.21% | 22.41B | |
| Average | -0.49% | -0.34% | -3.10% | +7.90% | 61.12B | |
| Weighted average by Cap. | -0.45% | -2.34% | +10.54% | +25.32% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.4M 1.2M 1.13M 1.05M 1.93M 126M 2.1M 13.07M 5.08M 59.54M 5.25M 5.14M 219M | 825K 709K 665K 620K 1.14M 74.16M 1.24M 7.72M 3M 35.15M 3.1M 3.03M 130M |
| Net income | -8.15M -7.01M -6.57M -6.12M -11.28M -733M -12.26M -76.21M -29.62M -347M -30.59M -29.95M -1.28B | -18.52M -15.91M -14.93M -13.91M -25.61M -1.66B -27.84M -173M -67.28M -789M -69.49M -68.02M -2.91B |
| Net Debt | -1.74M -1.5M -1.4M -1.31M -2.41M -157M -2.62M -16.29M -6.33M -74.2M -6.54M -6.4M -273M | -1.93M -1.66M -1.56M -1.45M -2.68M -174M -2.91M -18.09M -7.03M -82.4M -7.26M -7.11M -304M |
More financial data
* Estimated data
Employees
35
- Stock Market
- Equities
- BELL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition